Skip Nav Destination
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS|
January 19, 2023
Relapse in thrombotic thrombocytopenic purpura
CME
Blood (2023) 141 (3): 321.
Connected Content
A related article has been published:
Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy
Citation
Relapse in thrombotic thrombocytopenic purpura. Blood 2023; 141 (3): 321. doi: https://doi.org/10.1182/blood.2022019297
Download citation file:
January 19 2023
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal